Being told that your baby is measuring large can raise a lot of questions.
Will my baby be safe during a vaginal birth? Should I be induced? Do I need a cesarean section? And if my doctor recommends waiting for labor to begin naturally, is that still an approach supported by the latest research?
These questions have become particularly important following two recent developments in the medical literature: the 2025 Big Baby Trial and a 2026 meta-analysis examining induction for babies suspected to be large for gestational age.
The research does not mean that every pregnant patient with a large baby should be induced. It also does not establish a new universal standard of care.
What it does is add important evidence to a conversation that has historically focused largely on one question: Should a cesarean delivery be considered?
The newer research raises another possibility: Could earlier induction of labor reduce the risk of shoulder dystocia for some patients?
What Does “Large for Gestational Age” Mean?
You may hear your doctor use the term large for gestational age, or LGA.
LGA generally refers to a fetus whose estimated weight is above the 90th percentile for its gestational age. In other words, the baby is estimated to be larger than most babies at the same point in pregnancy.
This is different from simply saying that a baby has a high birthweight.
A baby’s size is only one factor associated with shoulder dystocia, a delivery complication that occurs when the baby’s shoulders become stuck after the head has delivered. Shoulder dystocia can occur even when a baby is not considered particularly large.
At the same time, fetal size remains an important risk factor.
That is why clinicians have traditionally paid close attention to estimated fetal weight, particularly when other risk factors are present.
Why Has Fetal Size Mattered in Decisions About Delivery?
For years, the discussion surrounding suspected fetal macrosomia has largely centered on whether cesarean delivery should be considered.
Current ACOG guidance supports consideration and counseling regarding prophylactic cesarean delivery at estimated fetal weights of approximately 4,500 grams in patients with diabetes and 5,000 grams in patients without diabetes.
But most babies suspected of being large do not reach those thresholds.
That creates a difficult clinical question: If a baby appears to be growing rapidly or measuring large but is not large enough for a planned cesarean, what other options should be considered?
Historically, many patients were managed expectantly, meaning the pregnancy continued while clinicians monitored the pregnancy and waited for labor to begin naturally.
One reason was uncertainty about whether inducing labor earlier actually improved outcomes. There were also concerns about the accuracy of ultrasound estimates, the relatively low absolute incidence of shoulder dystocia, the potential risks associated with early-term delivery, and the longstanding belief that induction could increase the likelihood of cesarean delivery.
The newest research is beginning to challenge some of those assumptions.
Could Inducing Labor Earlier Reduce the Risk?
The 2025 Big Baby Trial was the largest randomized trial to date examining this question. Nearly 2,900 pregnant patients with babies suspected to be large for gestational age were assigned either to induction between 38 weeks and 38 weeks, 4 days or to standard care.
The results are important, but they require some context.
In the study’s primary intention-to-treat analysis, shoulder dystocia occurred in 2.3% of the induction group compared with 3.1% of the standard-care group. That difference was not statistically significant.
One complication was that nearly one-quarter of patients assigned to standard care actually delivered, went into labor, or were induced by 38 weeks, 4 days. That made the two groups more similar than researchers had intended.
When researchers separately analyzed participants according to whether they actually received the planned timing of delivery, the results were different. Shoulder dystocia occurred in 2.3% of the induction group compared with 3.7% of the standard-care group, a statistically significant difference.
The study also found lower birthweights, fewer cesarean deliveries and less postpartum hemorrhage with induction, without an increase in adverse neonatal outcomes.
That does not mean the trial proved that every baby suspected to be large should be delivered at 38 weeks.
Instead, it adds important evidence that timing of delivery may be one way to modify risk in selected pregnancies.
What Did the 2026 Meta-Analysis Find?
The Big Baby Trial is not the only study pointing in this direction.
A 2026 meta-analysis combined five randomized controlled trials involving more than 4,000 patients. Most involved induction at approximately 38 weeks for fetuses suspected to be large for gestational age or macrosomic.
The analysis found a statistically significant reduction in cesarean delivery and substantial reductions in the number of babies ultimately weighing more than 4,000 grams and 4,500 grams. It also found a trend toward fewer shoulder dystocias and neonatal fractures, without evidence of increased major maternal or neonatal morbidity.
The researchers concluded that induction at 38 weeks was associated with reduced cesarean delivery and macrosomia and a potential reduction in shoulder dystocia and neonatal fracture. They suggested that induction before 39 weeks could be considered in selected patients after appropriate counseling. The strongest evidence involved induction between 38 weeks and 38 weeks, 4 days.
But the authors also emphasized an important limitation: predicting fetal size by ultrasound remains imprecise.
Taken together, the research does not give us a simple rule that “large baby = induction.”
Instead, it adds another option to the conversation about how fetal growth, other risk factors, and timing of delivery should be weighed together.
What About the Fact That Ultrasound Estimates Can Be Wrong?
This is an important limitation.
In the Big Baby Trial, participants entered the study because ultrasound suggested that their baby was above the 90th percentile. Yet only about 40% ultimately delivered a baby whose birthweight was above the 90th percentile.
So an ultrasound estimate should not be treated as a guarantee of what a baby will weigh at birth.
But imperfect does not mean irrelevant.
The question is not whether an ultrasound can predict a baby’s exact birthweight. Fetal size is one piece of clinical information, and the more useful question may be how that information fits with everything else known about the pregnancy.
That means a single estimated fetal weight may not tell the whole story.
Growth trajectories and percentiles can matter too. Clinicians may consider whether the baby has consistently measured large, whether the baby’s growth percentile has changed over time, and whether other risk factors are present.
Why One Risk Factor May Not Tell the Whole Story
Shoulder dystocia is difficult to predict. It can happen with babies who are not considered large, and many large babies are delivered vaginally without shoulder dystocia.
But “difficult to predict” does not mean that risk factors are meaningless.
One thing I pay close attention to in the birth injury cases I review is what I think of as risk stacking.
A single risk factor may not dramatically change the delivery plan. But what happens when several factors are present?
A baby measuring large. A growth percentile that is increasing. Maternal diabetes. A history of delivering a large baby. A prior shoulder dystocia. Other maternal or obstetric factors.
The question becomes less about whether any one factor can predict shoulder dystocia and more about whether the overall clinical picture should prompt a discussion about delivery timing and options.
That is also why looking only at one estimated fetal weight can miss part of the story. Growth trajectory, serial measurements, maternal history and other clinical factors may provide important context.
What About Diabetes?
Diabetes deserves particular attention because it can affect both fetal growth and decisions about delivery.
It is also important to understand that the Big Baby Trial did not study every type of pregnancy involving diabetes in the same way. Patients receiving insulin or oral medication for diabetes or gestational diabetes were excluded from the trial.
That means the results should not simply be assumed to apply identically to every pregnancy complicated by diabetes.
This is another reason individualized counseling matters. Fetal size should be considered alongside maternal health, diabetes status, pregnancy history, gestational age and other clinical factors.
Does This Mean Every Large Baby Should Be Induced?
No.
The Big Baby Trial and the 2026 meta-analysis provide important new evidence, but they do not establish that every patient with a suspected large baby should be induced at 38 weeks.
Induction is an intervention, and interventions have benefits and risks.
The decision may depend on a combination of factors, including the baby’s estimated size and growth pattern, gestational age, maternal health, diabetes, previous pregnancy history, previous macrosomia or shoulder dystocia, and other clinical considerations.
The goal is not simply more induction.
The goal is better, individualized decision-making based on the best available evidence and the circumstances of a particular pregnancy.
What Should Parents Ask Their Doctor?
If you have been told that your baby is measuring large, this research may give you additional questions to discuss with your obstetrician or midwife:
- What percentile is my baby measuring at?
- Has my baby’s growth pattern or percentile changed over time?
- How reliable is the estimated fetal weight in my particular situation?
- Do I have other risk factors for shoulder dystocia?
- How do my individual risk factors affect the overall picture?
- What are the potential benefits and risks of waiting for labor?
- What are the potential benefits and risks of induction?
- At what gestational age would you recommend delivery, and why?
- Would my circumstances make earlier induction reasonable?
- How would induction affect the possibility of cesarean delivery?
- What would you recommend if the baby continues to grow rapidly?
These questions do not mean that induction is necessarily the right choice.
They can help patients understand their individual risk factors, the available options, and why their healthcare provider is recommending a particular approach.
What Does This Mean for Birth Injury Cases?
From my perspective as a birth injury lawyer, this is where the newer research becomes particularly interesting.
Historically, shoulder dystocia cases involving a suspected large baby have often focused on one question:
Was the estimated fetal weight high enough that a cesarean delivery should have been discussed?
The newer research may broaden that analysis.
The question may not simply be whether a baby crossed a particular weight threshold. It may also be whether clinicians recognized the overall risk picture, followed fetal growth appropriately, considered how multiple risk factors interacted, and counseled the patient about reasonable delivery options.
In a birth injury case involving shoulder dystocia, I may look closely at:
- serial growth measurements and growth trajectory;
- estimated fetal weight and percentile;
- diabetes;
- prior macrosomia;
- prior shoulder dystocia;
- other maternal or obstetric risk factors;
- whether induction was discussed;
- whether cesarean delivery was discussed; and
- what the patient was told about the risks and benefits of waiting.
None of these factors, standing alone, automatically establishes medical negligence.
And these newer studies do not create a universal legal or medical requirement to induce every patient with a suspected large baby.
But they do add to an evolving body of evidence about what may be possible before a shoulder dystocia ever occurs.
The central question may therefore become broader than simply whether the baby was large enough to justify a cesarean.
It may include whether the available information identified increased risk and whether the patient received appropriate counseling about reasonable options for managing that risk.
The Bigger Takeaway: Look at the Whole Pregnancy
If your baby is measuring large, there may not be one number that tells you the “right” way to deliver.
Ultrasound estimates are imperfect. Shoulder dystocia cannot be predicted with certainty. Many large babies are delivered vaginally without complication, and shoulder dystocia can occur in babies of average size.
But uncertainty does not mean that risk factors should be ignored.
The newer research gives patients and clinicians more information to consider when discussing fetal growth and delivery timing. And it reinforces something I see repeatedly in the birth injury cases I review: the entire clinical picture matters.
How large is the baby estimated to be? Is the growth percentile changing? Is diabetes present? Is there a history of macrosomia or shoulder dystocia? Are other risk factors beginning to stack up?
The goal is not automatically more induction or more cesarean deliveries.
The goal is informed, individualized decision-making before labor begins.
This article is for general informational purposes only and is not medical or legal advice. Decisions about pregnancy and delivery should be made in consultation with your healthcare provider based on your individual circumstances.
Sources
- Gardosi J, et al. Induction of Labour Versus Standard Care to Prevent Shoulder Dystocia in Fetuses Suspected to be Large for Gestational Age in the UK (The Big Baby Trial). The Lancet. 2025;405:1743–1756.
- Paladino M, Berghella V. Induction at 38 Weeks for Large-for-Gestational-Age or Macrosomic Fetuses Decreases the Incidence of Cesarean Delivery: Meta-analysis of Randomized Controlled Trials. American Journal of Obstetrics & Gynecology MFM. 2026.